✦ LIBER ✦

PMS11 COST-EFFECTIVENESS ANALYSIS OF RITUXIMAB FOR RHEUMATOID ARTHRITIS IN TAIWAN

✍ Scribed by SF Lou; DY Chen; TT Cheng; CM Huang; HY Lin; CC Su; WC Tsai; JC Tseng; CC Wei; L Yang; S Hazard; DM Chang

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS27 COST CONSEQUENCE ANALYSIS OF RITUX

✍ A Hammerman; SH Klang; N Liebermann; T Birenboim-Gal; A Shuali; M Kfir 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

PMS21 COST-EFFECTIVENESS SIMULATION MODE

✍ L Gossec; P Goupille; A Saraux; B Bregman; E Boccard; D Dupont; A Beresniak 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

PMS13 Cost-Effectiveness of Biological T

✍ Chen, H.F.; Lin, H.Y.; Lang, H.C. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

PMS31 Cost-Effectiveness Analysis of Gol

✍ R.J. Desai; J. Rao; A.K. Biddle 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PMS70 COST-EFFECTIVENESS OF ETANERCEPT V

✍ X Gao; S Hwang; KT Carpiuc; JM Stephens; R Sato; A Singh 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PMS21 ABATACEPT OR INFLIXIMAB FOR RHEUMA

✍ R. Alfonso-Cristancho; N. Serra; E.C. Aiello; C.N. Roa 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB